Should we treat aging as a disease? The consequences and dangers of miscategorisation

• Published in: Frontiers in genetics 2015-07, Vol.6, p.171-171
• Main Author: Faragher, Richard G A
• Format: Article
• Language: English
• Subjects: Ethics, Medical; Genetics; History; Philosophy; rapamycin; senescence; Werner Syndrome
• ISSN: 1664-8021; 1664-8021
• DOI: 10.3389/fgene.2015.00171

The aging of the population represents one of the largest healthcare challenges facing the world today. The available scientific evidence shows that interventions are available now that can target fundamental "aging" processes or pathways. Sufficient economic evidence is available to argue convincingly that this approach will also save enormous sums of money which could then be deployed to solve other urgent global problems. However, as yet this scenario has barely entered the public consciousness and, far from being a point of vigorous debate, seems to be ignored by policy makers. Understanding why this lethargy exists is important given the urgent need to deal with the challenge represented by population aging. In this paper I hypothesize that one major cause of inaction is a widely held, but flawed, conceptual framework concerning the relationship between aging and disease that categorizes the former as "natural" and the latter as "abnormal." This perspective is sufficient in itself to act as a disincentive to intervention by rendering those who hold it prone to the "naturalistic fallacy" but can give rise to active hostility to biogerontology if coupled with loose and/or blurred understanding of the goals and potential of the field.